ID   CNR1_RAT                Reviewed;         473 AA.
AC   P20272;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Cannabinoid receptor 1;
DE            Short=CB-R;
DE            Short=CB1;
DE   AltName: Full=Brain-type cannabinoid receptor;
GN   Name=Cnr1; Synonyms=Skr6 {ECO:0000303|PubMed:2165569};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=2165569; DOI=10.1038/346561a0;
RA   Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I.;
RT   "Structure of a cannabinoid receptor and functional expression of the
RT   cloned cDNA.";
RL   Nature 346:561-564(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8832654; DOI=10.1016/0304-3940(96)12792-0;
RA   Ho B.Y., Zhao J.;
RT   "Determination of the cannabinoid receptors in mouse x rat hybridoma NG108-
RT   15 cells and rat GH4C1 cells.";
RL   Neurosci. Lett. 212:123-126(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-107.
RX   PubMed=7876112; DOI=10.1074/jbc.270.8.3726;
RA   Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M.,
RA   Le Fur G., Caput D., Ferrara P.;
RT   "An amino-terminal variant of the central cannabinoid receptor resulting
RT   from alternative splicing.";
RL   J. Biol. Chem. 270:3726-3731(1995).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10362691; DOI=10.1152/ajpheart.1999.276.6.h2085;
RA   Gebremedhin D., Lange A.R., Campbell W.B., Hillard C.J., Harder D.R.;
RT   "Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to
RT   inhibit L-type Ca2+ channel current.";
RL   Am. J. Physiol. 276:H2085-H2093(1999).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10891614; DOI=10.1016/s0306-4522(00)00157-3;
RA   Denovan-Wright E.M., Robertson H.A.;
RT   "Cannabinoid receptor messenger RNA levels decrease in a subset of neurons
RT   of the lateral striatum, cortex and hippocampus of transgenic Huntington's
RT   disease mice.";
RL   Neuroscience 98:705-713(2000).
RN   [6]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND TISSUE SPECIFICITY.
RX   PubMed=16033894; DOI=10.1523/jneurosci.0442-05.2005;
RA   Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N.,
RA   Freund T.F.;
RT   "Endocannabinoid signaling in rat somatosensory cortex: laminar differences
RT   and involvement of specific interneuron types.";
RL   J. Neurosci. 25:6845-6856(2005).
RN   [7]
RP   INTERACTION WITH CNRIP1.
RC   TISSUE=Brain;
RX   PubMed=17895407; DOI=10.1124/mol.107.039263;
RA   Niehaus J.L., Liu Y., Wallis K.T., Egertova M., Bhartur S.G.,
RA   Mukhopadhyay S., Shi S., He H., Selley D.E., Howlett A.C., Elphick M.R.,
RA   Lewis D.L.;
RT   "CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor
RT   interacting protein CRIP 1a.";
RL   Mol. Pharmacol. 72:1557-1566(2007).
RN   [8]
RP   ACTIVITY REGULATION.
RX   PubMed=18077343; DOI=10.1073/pnas.0706980105;
RA   Heimann A.S., Gomes I., Dale C.S., Pagano R.L., Gupta A., de Souza L.L.,
RA   Luchessi A.D., Castro L.M., Giorgi R., Rioli V., Ferro E.S., Devi L.A.;
RT   "Hemopressin is an inverse agonist of CB1 cannabinoid receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20588-20593(2007).
RN   [9]
RP   INTERACTION WITH GNAI3 AND GNAO1, AND PALMITOYLATION AT CYS-416.
RX   PubMed=21895628; DOI=10.1111/j.1476-5381.2011.01658.x;
RA   Oddi S., Dainese E., Sandiford S., Fezza F., Lanuti M., Chiurchiu V.,
RA   Totaro A., Catanzaro G., Barcaroli D., De Laurenzi V., Centonze D.,
RA   Mukhopadhyay S., Selent J., Howlett A.C., Maccarrone M.;
RT   "Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid
RT   receptor on membrane localization and signalling.";
RL   Br. J. Pharmacol. 165:2635-2651(2012).
RN   [10]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23955712; DOI=10.1038/nm.3265;
RA   Jourdan T., Godlewski G., Cinar R., Bertola A., Szanda G., Liu J., Tam J.,
RA   Han T., Mukhopadhyay B., Skarulis M.C., Ju C., Aouadi M., Czech M.P.,
RA   Kunos G.;
RT   "Activation of the Nlrp3 inflammasome in infiltrating macrophages by
RT   endocannabinoids mediates beta cell loss in type 2 diabetes.";
RL   Nat. Med. 19:1132-1140(2013).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=26671069; DOI=10.1371/journal.pone.0145244;
RA   Arrabal S., Lucena M.A., Canduela M.J., Ramos-Uriarte A., Rivera P.,
RA   Serrano A., Pavon F.J., Decara J., Vargas A., Baixeras E.,
RA   Martin-Rufian M., Marquez J., Fernandez-Llebrez P., De Roos B., Grandes P.,
RA   Rodriguez de Fonseca F., Suarez J.;
RT   "Pharmacological blockade of cannabinoid CB1 receptors in diet-induced
RT   obesity regulates mitochondrial dihydrolipoamide dehydrogenase in muscle.";
RL   PLoS ONE 10:E0145244-E0145244(2015).
CC   -!- FUNCTION: G-protein coupled receptor for cannabinoids, including
CC       endocannabinoids (eCBs), such as N-arachidonoylethanolamide (also
CC       called anandamide or AEA) and 2-arachidonoylglycerol (2-AG)
CC       (PubMed:2165569). Mediates many cannabinoid-induced effects, acting,
CC       among others, on food intake, memory loss, gastrointestinal motility,
CC       catalepsy, ambulatory activity, anxiety, chronic pain. Signaling
CC       typically involves reduction in cyclic AMP. In the hypothalamus, may
CC       have a dual effect on mitochondrial respiration depending upon the
CC       agonist dose and possibly upon the cell type. Increases respiration at
CC       low doses, while decreases respiration at high doses. At high doses,
CC       CNR1 signal transduction involves G-protein alpha-i protein activation
CC       and subsequent inhibition of mitochondrial soluble adenylate cyclase,
CC       decrease in cyclic AMP concentration, inhibition of protein kinase A
CC       (PKA)-dependent phosphorylation of specific subunits of the
CC       mitochondrial electron transport system, including NDUFS2. In the
CC       hypothalamus, inhibits leptin-induced reactive oxygen species (ROS)
CC       formation and mediates cannabinoid-induced increase in SREBF1 and FASN
CC       gene expression. In response to cannabinoids, drives the release of
CC       orexigenic beta-endorphin, but not that of melanocyte-stimulating
CC       hormone alpha/alpha-MSH, from hypothalamic POMC neurons, hence
CC       promoting food intake. In the hippocampus, regulates cellular
CC       respiration and energy production in response to cannabinoids. Involved
CC       in cannabinoid-dependent depolarization-induced suppression of
CC       inhibition (DSI), a process in which depolarization of CA1 postsynaptic
CC       pyramidal neurons mobilizes eCBs, which retrogradely activate
CC       presynaptic CB1 receptors, transiently decreasing GABAergic inhibitory
CC       neurotransmission. Also reduces excitatory synaptic transmission (By
CC       similarity). In superior cervical ganglions and cerebral vascular
CC       smooth muscle cells, inhibits voltage-gated Ca(2+) channels in a
CC       constitutive, as well as agonist-dependent manner (By similarity).
CC       Induces leptin production in adipocytes and reduces LRP2-mediated
CC       leptin clearance in the kidney, hence participating in hyperleptinemia.
CC       In adipose tissue, CNR1 signaling leads to increased expression of
CC       SREBF1, ACACA and FASN genes. In the liver, activation by
CC       endocannabinoids leads to increased de novo lipogenesis and reduced
CC       fatty acid catabolism, associated with increased expression of
CC       SREBF1/SREBP-1, GCK, ACACA, ACACB and FASN genes. May also affect de
CC       novo cholesterol synthesis and HDL-cholesteryl ether uptake (By
CC       similarity). Peripherally modulates energy metabolism. In high
CC       carbohydrate diet-induced obesity, may decrease the expression of
CC       mitochondrial dihydrolipoyl dehydrogenase/DLD in striated muscles, as
CC       well as that of selected glucose/ pyruvate metabolic enzymes, hence
CC       affecting energy expenditure through mitochondrial metabolism
CC       (PubMed:26671069). In response to cannabinoid anandamide, elicits a
CC       pro-inflammatory response in macrophages, which involves NLRP3
CC       inflammasome activation and IL1B and IL18 secretion. In macrophages
CC       infiltrating pancreatic islets, this process may participate in the
CC       progression of type-2 diabetes and associated loss of pancreatic beta-
CC       cells (PubMed:23955712). {ECO:0000250|UniProtKB:O02777,
CC       ECO:0000250|UniProtKB:P47746, ECO:0000269|PubMed:2165569,
CC       ECO:0000269|PubMed:23955712, ECO:0000269|PubMed:26671069}.
CC   -!- ACTIVITY REGULATION: Hemopressin, a peptide derived from hemoglobin
CC       subunit alpha (HBA1 and/or HBA2), acts as an antagonist peptide:
CC       hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and
CC       subsequent signaling. {ECO:0000269|PubMed:18077343}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with CNRIP1 (PubMed:17895407).
CC       Associates with G protein alpha subunits, including G(i) alpha-1/GNAI1,
CC       G(i) alpha-3/GNAI3 and G(o)-alpha/GNAO1; palmitoylation is important
CC       for interaction with GNAI3 and GNAO1 (PubMed:21895628).
CC       {ECO:0000269|PubMed:17895407, ECO:0000269|PubMed:21895628}.
CC   -!- INTERACTION:
CC       P20272; P30543: Adora2a; NbExp=3; IntAct=EBI-2909800, EBI-2902822;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P47746};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P21554}.
CC       Mitochondrion outer membrane {ECO:0000250|UniProtKB:P47746}. Cell
CC       projection, axon {ECO:0000269|PubMed:16033894}. Presynapse
CC       {ECO:0000269|PubMed:16033894}. Note=Unexpectedly, in the mitochondria,
CC       the C-terminus is located in the mitochondrial intermembrane space, a
CC       compartment topologically considered as extracellular. In canonical
CC       seven-transmembrane G-protein coupled receptors, the C-terminus is
CC       cytosolic (By similarity). In interneurons, found on the membrane of
CC       cytoplasmic compartments, some of which could be elements of the
CC       endosome-lysosome system and multivesicular bodies (PubMed:16033894).
CC       Found on presynaptic axon terminals in some GABAergic neurons in the
CC       somatosensory cortex (PubMed:16033894). {ECO:0000250|UniProtKB:P47746,
CC       ECO:0000269|PubMed:16033894}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, in the striatum, medial
CC       septum, descending arm of the band of Broca, the amygdaloid nucleus,
CC       the hippocampus and cortex (at protein level). High levels in the
CC       lateral striatum. In rostral brain regions, high expression levels in
CC       the dorsal lateral striatum, while in the caudal brain regions, high
CC       levels are observed in the ventral lateral striatum (PubMed:10362691,
CC       PubMed:10891614, PubMed:16033894, PubMed:2165569). Expressed in
CC       monocytes/macrophages (at protein level) (PubMed:23955712). Expressed
CC       in striated muscles and in vascular smooth muscles cells (at protein
CC       level) (PubMed:10362691, PubMed:26671069).
CC       {ECO:0000269|PubMed:10362691, ECO:0000269|PubMed:10891614,
CC       ECO:0000269|PubMed:16033894, ECO:0000269|PubMed:2165569,
CC       ECO:0000269|PubMed:23955712, ECO:0000269|PubMed:26671069}.
CC   -!- PTM: Palmitoylation at Cys-416 is important for recruitment at both
CC       plasma membrane and lipid rafts and association with G protein alpha
CC       subunits. {ECO:0000269|PubMed:21895628}.
CC   -!- MISCELLANEOUS: High-fat diet also increases the hepatic levels of CNR1
CC       ligand anandamide, but not that of 2-arachidonoylglycerol.
CC       {ECO:0000250|UniProtKB:P47746}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X55812; CAA39332.1; -; mRNA.
DR   EMBL; U40395; AAA99067.1; -; mRNA.
DR   PIR; A33117; A33117.
DR   RefSeq; NP_036916.1; NM_012784.4.
DR   RefSeq; XP_006238046.1; XM_006237984.3.
DR   RefSeq; XP_017448640.1; XM_017593151.1.
DR   AlphaFoldDB; P20272; -.
DR   SMR; P20272; -.
DR   BioGRID; 247288; 3.
DR   IntAct; P20272; 3.
DR   MINT; P20272; -.
DR   STRING; 10116.ENSRNOP00000010850; -.
DR   BindingDB; P20272; -.
DR   ChEMBL; CHEMBL3571; -.
DR   DrugCentral; P20272; -.
DR   GuidetoPHARMACOLOGY; 56; -.
DR   GlyCosmos; P20272; 2 sites, No reported glycans.
DR   GlyGen; P20272; 2 sites.
DR   iPTMnet; P20272; -.
DR   PhosphoSitePlus; P20272; -.
DR   SwissPalm; P20272; -.
DR   PaxDb; 10116-ENSRNOP00000010850; -.
DR   Ensembl; ENSRNOT00000010850.3; ENSRNOP00000010850.1; ENSRNOG00000008223.3.
DR   Ensembl; ENSRNOT00000099728.1; ENSRNOP00000081243.1; ENSRNOG00000008223.3.
DR   Ensembl; ENSRNOT00000101534.1; ENSRNOP00000085179.1; ENSRNOG00000008223.3.
DR   Ensembl; ENSRNOT00000117169.1; ENSRNOP00000079932.1; ENSRNOG00000008223.3.
DR   Ensembl; ENSRNOT00055028545; ENSRNOP00055022984; ENSRNOG00055016812.
DR   Ensembl; ENSRNOT00055028548; ENSRNOP00055022987; ENSRNOG00055016812.
DR   Ensembl; ENSRNOT00055028551; ENSRNOP00055022990; ENSRNOG00055016812.
DR   Ensembl; ENSRNOT00055028555; ENSRNOP00055022993; ENSRNOG00055016812.
DR   Ensembl; ENSRNOT00060023667; ENSRNOP00060018819; ENSRNOG00060013854.
DR   Ensembl; ENSRNOT00060023669; ENSRNOP00060018821; ENSRNOG00060013854.
DR   Ensembl; ENSRNOT00060023671; ENSRNOP00060018823; ENSRNOG00060013854.
DR   Ensembl; ENSRNOT00060023677; ENSRNOP00060018829; ENSRNOG00060013854.
DR   Ensembl; ENSRNOT00065007116; ENSRNOP00065004927; ENSRNOG00065004895.
DR   Ensembl; ENSRNOT00065007118; ENSRNOP00065004929; ENSRNOG00065004895.
DR   Ensembl; ENSRNOT00065007119; ENSRNOP00065004930; ENSRNOG00065004895.
DR   Ensembl; ENSRNOT00065007121; ENSRNOP00065004932; ENSRNOG00065004895.
DR   GeneID; 25248; -.
DR   KEGG; rno:25248; -.
DR   UCSC; RGD:2369; rat.
DR   AGR; RGD:2369; -.
DR   CTD; 1268; -.
DR   RGD; 2369; Cnr1.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01120000271819; -.
DR   HOGENOM; CLU_009579_7_0_1; -.
DR   InParanoid; P20272; -.
DR   OMA; ERCIKNT; -.
DR   OrthoDB; 5258261at2759; -.
DR   PhylomeDB; P20272; -.
DR   TreeFam; TF330052; -.
DR   Reactome; R-RNO-373076; Class A/1 (Rhodopsin-like receptors).
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:P20272; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000008223; Expressed in Ammon's horn and 11 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:CACAO.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0004949; F:cannabinoid receptor activity; IMP:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007413; P:axonal fasciculation; ISO:RGD.
DR   GO; GO:0038171; P:cannabinoid signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEP:RGD.
DR   GO; GO:0007613; P:memory; IDA:RGD.
DR   GO; GO:0045759; P:negative regulation of action potential; IMP:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IMP:RGD.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD.
DR   GO; GO:0031999; P:negative regulation of fatty acid beta-oxidation; IMP:RGD.
DR   GO; GO:0033004; P:negative regulation of mast cell activation; IDA:RGD.
DR   GO; GO:0043271; P:negative regulation of monoatomic ion transport; IDA:RGD.
DR   GO; GO:0014063; P:negative regulation of serotonin secretion; IMP:CACAO.
DR   GO; GO:0002866; P:positive regulation of acute inflammatory response to antigenic stimulus; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IMP:RGD.
DR   GO; GO:0031622; P:positive regulation of fever generation; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0060259; P:regulation of feeding behavior; IMP:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IMP:RGD.
DR   GO; GO:0019222; P:regulation of metabolic process; IBA:GO_Central.
DR   GO; GO:0060405; P:regulation of penile erection; IMP:RGD.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IMP:RGD.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IMP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IMP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IMP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IMP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0098921; P:retrograde trans-synaptic signaling by endocannabinoid; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   GO; GO:0099553; P:trans-synaptic signaling by endocannabinoid, modulating synaptic transmission; ISO:RGD.
DR   CDD; cd15340; 7tmA_CB1; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000810; Canbinoid_rcpt_1.
DR   InterPro; IPR002230; Cnbnoid_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR22750:SF47; CANNABINOID RECEPTOR 1; 1.
DR   PANTHER; PTHR22750; G-PROTEIN COUPLED RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PIRSF; PIRSF037995; Cnoid_rcpt_1; 1.
DR   PRINTS; PR00522; CANABINOID1R.
DR   PRINTS; PR00362; CANNABINOIDR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; G-protein coupled receptor; Glycoprotein;
KW   Lipoprotein; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Palmitate; Phosphoprotein; Receptor; Reference proteome; Synapse;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..473
FT                   /note="Cannabinoid receptor 1"
FT                   /id="PRO_0000069318"
FT   TOPO_DOM        1..117
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        118..143
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        144..155
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        156..176
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        177..188
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        189..213
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        214..233
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        234..256
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        257..274
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        275..300
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        301..345
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        346..366
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        367..378
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TRANSMEM        379..400
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   TOPO_DOM        401..473
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P21554"
FT   REGION          2..23
FT                   /note="Required for mitochondrial localization"
FT                   /evidence="ECO:0000250|UniProtKB:P47746"
FT   MOD_RES         426
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P47746"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P47746"
FT   LIPID           416
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:21895628"
FT   CARBOHYD        78
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        84
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   473 AA;  52845 MW;  E59A66AFE17B646C CRC64;
     MKSILDGLAD TTFRTITTDL LYVGSNDIQY EDIKGDMASK LGYFPQKFPL TSFRGSPFQE
     KMTAGDNSPL VPAGDTTNIT EFYNKSLSSF KENEENIQCG ENFMDMECFM ILNPSQQLAI
     AVLSLTLGTF TVLENLLVLC VILHSRSLRC RPSYHFIGSL AVADLLGSVI FVYSFVDFHV
     FHRKDSPNVF LFKLGGVTAS FTASVGSLFL TAIDRYISIH RPLAYKRIVT RPKAVVAFCL
     MWTIAIVIAV LPLLGWNCKK LQSVCSDIFP LIDETYLMFW IGVTSVLLLF IVYAYMYILW
     KAHSHAVRMI QRGTQKSIII HTSEDGKVQV TRPDQARMDI RLAKTLVLIL VVLIICWGPL
     LAIMVYDVFG KMNKLIKTVF AFCSMLCLLN STVNPIIYAL RSKDLRHAFR SMFPSCEGTA
     QPLDNSMGDS DCLHKHANNT ASMHRAAESC IKSTVKIAKV TMSVSTDTSA EAL
//
